Literature DB >> 11228754

Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.

M R Burge1, V Sood, T A Sobhy, A G Rassam, D S Schade.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 11228754     DOI： 10.1046/j.1463-1326.1999.00031.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN： 1462-8902            Impact factor:   6.577


× No keyword cloud information.
  11 in total

1.  Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.

Authors:  Nobuyuki Negoro; Shinobu Sasaki; Satoshi Mikami; Masahiro Ito; Masami Suzuki; Yoshiyuki Tsujihata; Ryo Ito; Ayako Harada; Koji Takeuchi; Nobuhiro Suzuki; Junichi Miyazaki; Takashi Santou; Tomoyuki Odani; Naoyuki Kanzaki; Miyuki Funami; Toshimasa Tanaka; Akifumi Kogame; Shinichiro Matsunaga; Tsuneo Yasuma; Yu Momose
Journal:  ACS Med Chem Lett       Date:  2010-06-18       Impact factor: 4.345

2.  Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes.

Authors:  Narihiro Toda; Xiaolin Hao; Yasuyuki Ogawa; Kozo Oda; Ming Yu; Zice Fu; Yi Chen; Yongjae Kim; Mike Lizarzaburu; Sarah Lively; Shauna Lawlis; Michiko Murakoshi; Futoshi Nara; Nobuaki Watanabe; Jeff D Reagan; Hui Tian; Angela Fu; Alykhan Motani; Qingxiang Liu; Yi-Jyun Lin; Run Zhuang; Yumei Xiong; Peter Fan; Julio Medina; Leping Li; Masanori Izumi; Ryo Okuyama; Satoshi Shibuya
Journal:  ACS Med Chem Lett       Date:  2013-06-17       Impact factor: 4.345

Review 3.  Are sulfonylureas passé?

Authors:  Jennifer B Green; Mark N Feinglos
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

Review 4.  Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence.

Authors:  Michaela Diamant; Robert J Heine
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Persistence of initial oral antidiabetic treatment in patients with type 2 diabetes mellitus.

Authors:  György Jermendy; István Wittmann; László Nagy; Zoltán Kiss; György Rokszin; Zsolt Abonyi-Tóth; Lajos Katona; György Paragh; István Karádi; Béla Merkely
Journal:  Med Sci Monit       Date:  2012-02

6.  Synthesis of tryptoline-3-carboxylic Acid derivatives a novel antidiabetic agent.

Authors:  An Choudhary; Ms Kohli; A Kumar; A Joshi
Journal:  J Young Pharm       Date:  2011-04

Review 7.  Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide.

Authors:  Philippe E R Lheureux; Soheil Zahir; Andrea Penaloza; Mireille Gris
Journal:  Crit Care       Date:  2005-09-07       Impact factor: 9.097

8.  In vivo efficacy of HD0471953: a novel GPR119 agonist for the treatment of type 2 diabetes mellitus.

Authors:  So Ra Kim; Dae-Hoon Kim; Soo Hyun Park; Young Seok Kim; Chun Hwa Kim; Tae-Young Ha; Jin Yang; Jae-Keol Rhee
Journal:  J Diabetes Res       Date:  2013-12-12       Impact factor: 4.011

9.  Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes.

Authors:  Bob W van Roozendaal; Ines Krass
Journal:  Pharm World Sci       Date:  2009-07-23

10.  Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes.

Authors:  Lotta Walz; Billie Pettersson; Ulf Rosenqvist; Anna Deleskog; Gunilla Journath; Per Wändell
Journal:  Patient Prefer Adherence       Date:  2014-04-30       Impact factor: 2.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.